An indication for a pacemaker or implantable cardioverter-defibrillator (ICD) in a patient with an intracardiac shunt requires a balancing of the risks and benefits associated with a transvenous ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Complications related to transvenous pacemakers have ...

Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...

Bethesda, MD - Transvenous pacing leads can be guided to just above the right atrium and through a puncture into the pericardial space for positioning at the left ventricular apex, according to a ...

The implantable defibrillator with subcutaneous leads, designed in part to minimize the risk for potentially serious lead-related complications, has reached a milestone by turning in a "noninferior" ...

Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

Despite being at higher risk of complications overall, Medicare beneficiaries who receive a Micra leadless pacemaker (Medtronic) fare better than those implanted with traditional transvenous systems, ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...